When did ANI Pharmaceuticals report Q4 2024 earnings?

ANI Pharmaceuticals (ANIP) reported Q4 2024 earnings on February 28, 2025 before market open.

What were ANI Pharmaceuticals's Q4 2024 revenue and EPS?

ANI Pharmaceuticals reported revenue of $190.6M and eps of $1.63 for Q4 2024.

Did ANI Pharmaceuticals beat estimates in Q4 2024?

Revenue beat the consensus estimate of $170.0M by $20.6M. EPS beat the consensus estimate of $1.41 by $0.22.

Where can I find ANI Pharmaceuticals's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001023024-25-000015) directly on SEC EDGAR. The filing index links above go to sec.gov.

ANI Pharmaceuticals ANIP Q4 2024 Annual earnings

Reported February 28, 2025 · Before market open

Revenue$190.6MBeat by $20.6M

EPS$1.63Beat by $0.22

Revenue estimate$170.0M

EPS estimate$1.41

Next report

Aug 7, 2026 (In 1 week)

Revenue estimate$260.1M

EPS estimate$2.01

Financials

Q4 2024

Income statement

See full

Revenue$190.6M+44.8%

Gross profit$110.3M+41.0%

Net income-$10.3M-990%

EPS (diluted)-$0.55-2,850%

Balance sheet

See full

Cash & equivalents$144.9M-34.5%

Total debt$324.9M+11.5%

Total equity$403.7M-6.7%

Total assets$1.3B+42.0%

Cash flow

See full

Operating cash flow$15.9M-64.6%

CapEx$2.4M+5.0%

Free cash flow$13.5M-68.3%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.16B+3.2%

Enterprise value$1.34B+12.1%

P/S1.9×-0.4×

Profitability

See full

Gross margin59.3%-3.4pp

Net margin-3%-6.9pp

FCF margin7.8%-14.8pp

Returns & leverage

See full

Return on equity-4.4%-9.5pp

Debt / equity0.8×+0.1×

Current ratio2.7×-0.9×

Versus estimates

Revenue

Q1 2026$237.5MBeat by $29.8M Q4 2025$247.1MBeat by $16.0M Q3 2025$227.8MMiss by $4.4M Q2 2025$211.4MBeat by $2.6M Q1 2025$197.1MBeat by $8.4M

Q4 2024$190.6MBeat by $20.6M

Diluted EPS

Q1 2026$2.05Beat by $0.77 Q4 2025$2.33Beat by $0.34 Q3 2025$2.04Beat by $0.30 Q2 2025$1.80Beat by $0.42 Q1 2025$1.70Beat by $0.33

Q4 2024$1.63Beat by $0.22

Ask the moment ANI Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did ANI Pharmaceuticals report Q4 2024 earnings?: ANI Pharmaceuticals (ANIP) reported Q4 2024 earnings on February 28, 2025 before market open.
What were ANI Pharmaceuticals's Q4 2024 revenue and EPS?: ANI Pharmaceuticals reported revenue of $190.6M and eps of $1.63 for Q4 2024.
Did ANI Pharmaceuticals beat estimates in Q4 2024?: Revenue beat the consensus estimate of $170.0M by $20.6M. EPS beat the consensus estimate of $1.41 by $0.22.
Where can I find ANI Pharmaceuticals's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001023024-25-000015) directly on SEC EDGAR. The filing index links above go to sec.gov.